生体制御学講座 本文へジャンプ
業績(2016〜2020)

【原著】

1. Suzuki K, Takeuchi O, Suzuki Y, Kitagawa Y. Mechanisms of metformin‘s anti?tumor activity against gemcitabine?resistant pancreatic adenocarcinoma. Int J Oncol 2019 Feb;54(2):764-772

2. Yano K, Hirayama S, Misawa N, Furuta A, Ueno T, Motoi Y, Seino U, Ebinuma H, Ikeuchi T, Schneider WJ, Bujo H, Miida T. Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid-high-density lipoprotein. Clinica Chmica Acta, 2019, Feb 489;29-34.

3. Horiuchi Y, Ohkawa R, Lai SJ, Yamazaki A, Ikoma H, Yano K, Kameda T, Tozuka M. Characterization of the cholesterol efflux of apolipoprotein E-containing high-density lipoprotein in THP-1 cells. Biol Chem. 2019 Jan 28;400(2):209-218

4. Chie Taniguchi, Hideo Tanaka,Hideo Saka, Isao Oze, Kazunobu Tachibana, Yasuhiro Nozaki, Yukio Suzuki, Hisataka Sakakibara. Changes in self‐efficacy associated with success in quitting smoking in participants in Japanese smoking cessation therapy. Int J Nurs Pract 2018 Aug:24(4):e12647

5. Isshiki M, Hirayama S, Ueno T, Ito M, Furuta A, Yano K, Yamatani K, Sugihara M, Idei M, Miida T. Apolipoproteins C-II and C-III as nutritional markers unaffected by inflammation. Clinica Chimica Acta, 2018, Jun 481;225-230.

6. Horiuchi Y, Lai SJ, Yamazaki A, Nakamura A, Ohkawa R, Yano K, Kameda T, Okubo S, Shimano S, Hagihara M, Tohda S, Tozuka M. Validation and application of a novel cholesterol efflux assay using immobilized liposomes as a substitute for cultured cells. Bioscience reports, 2018, Apr 13;38(2).

7. Matsusaka M, Fukunaga K, Kabata H, Izuhara K, Asano K, Betsuyaku T. Subphenotypes of type 2 severe asthma in adults. J Allergy Clin Immunol Pract. 2018 Jan-Feb;6(1):274-276.

8. Kamatani T, Fukunaga K, Miyata K, Shirasaki Y, Tanaka J, Baba R, Matsusaka M, Kamatani N, Moro K, Betsuyaku T, Uemura S. Construction of a system using a deep learning algorithm to count cell numbers in nanoliter wells for viable single-cell experiments. Sci Rep. 2017 Dec 4;7(1):16831.

9. Masaki K, Fukunaga K,?Matsusaka M, Kabata H, Tanosaki T, Mochimaru T, Kamatani T, Ohtsuka K, Baba R, Ueda S, Suzuki Y, Sakamaki F, Oyamada Y, Inoue T, Oguma T, Sayama K, Koh H, Nakamura M, Umeda A, Kamei K, Izuhara K, Asano K, Betsuyaku T. Characteristics of Severe Asthma With Fungal Sensitization. Ann Allergy Asthma Immunol. 2017 Sep;119(3):253-257.

10. Chie Taniguchi, Hideo Tanaka, Hideo Saka, Isao Oze, Kazunobu Tachibana,Yasuhiro Nozaki,Yukio Suzuki,Hisataka Sakakibara Cognitive, behavioural and psychosocial factors associated with successful and maintained quit smoking status among patients who received smoking cessation intervention with nurses’counselling. J Adv Nurs 2017 Jul;73(7):1681-1695

11. Sasamoto K, Hirayama S, Kon M, Seino U, Ueno T, Nagao Y, Hirayama A, Isshiki M, Idei M, Yano K, Miida T. Changes in apolipoprotein E-containing high-density lipoprotein (HDL) have little impact on HDL-cholesterol measurements using homogeneous assays in normolipidemic and dyslipidemic subjects. Clinica Chimica Acta, 2017, Jul 470;56-63.

12. Takahashi H, Shimodaira S, Masahiro Ogasawara M, Shuichi Ota S,Kobayashi M, Abe H, Morita Y, Nagai K, Tsujitani S, Okamoto M, Suzuki Y, Nakanishi Y, Yonemitsu Y. Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell?based cancer vaccine than other subtypes of non?small cell lung cancers: a multicenter retrospective analysis. Cancer Immunol Immunother 2016 Sep;65(9):1099-111

13. Yano K, Ohkawa R, Sato M, Yoshimoto A, Ichimura N, Kameda T, Kubota T, Tozuka M. Cholesterol Efflux Capacity of Apolipoprotein A-I Varies with the Extent of Differentiation and Foam Cell Formation of THP-1 Cells. Journal of Lipids, 2016, Volume 2016.

14. Sato M, Ohkawa R, Yoshimoto A, Yano K, Ichimura N, Nishimori M, Okubo S, Yatomi Y, Tozuka M. Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein. Bioscience reports, 2016, Aug 16;36(4).



【総説・解説】

1. 鈴木幸男: 肺炎. 病気と薬2020, 薬局 増刊号71(4): pp695-705, 南江堂, 2020

2. 鈴木幸男: 間質性肺炎. 病気と薬2020, 薬局 増刊号71(4):pp706-711, 南江堂, 2020

3. 松坂雅子:喘息の表現型と分類の意義, Medical Practice36(12): pp1835-1840, 文光堂, 2019

4. 鈴木幸男: 喫煙をめぐる環境, 診断と治療 107(9):1099-1103,2019

5. 鈴木幸男: 化学物質過敏症. 禁煙学 改訂4版: pp103-106, 日本禁煙学会編, 南山堂, 2019

6. 鈴木幸男: 肺炎. 病気とくすり2018, 薬局 増刊号69(4): pp683-693, 南山堂, 2018

7. 鈴木幸男: 呼吸器疾患. ステロイド療法の極意, じほう: pp68-78, 2017

8. 鈴木幸男: 急性高山病. 今日の治療指針2017: pp1029-1030, 医学書院, 2017

9. 鈴木幸男: 肺炎. 病気とくすり2017, 薬局 増刊号68(4): pp677-686, 南江堂, 2017

10. 鈴木幸男: わが国における電子タバコの現状と問題点, 日臨床環境医学会誌26: pp24-30, 2017

11. 鈴木幸男: 呼吸器疾患. ステロイド療法のエッセンス, 薬事 増刊号 58(10): pp119-127, じほう, 2016

12. 鈴木幸男: 肺炎. 病気と薬2016, 薬局 増刊号67(4): pp663-672, 南江堂, 2016

13. 松坂雅子,浅野浩一郎:気管支喘息とバイオマーカー.Annual Review 2016 呼吸器: 92-97, 中外医学社, 2016

14. 鈴木幸男: 呼吸器疾患患者に投与するときの注意. 一冊できわめるステロイド診療ガイド: pp72-8, 文光堂, 2015